Restylane® and Perlane®: Commentary

Cosmetic Dermatology

Volumn 16, Issue 7, 2003, Pages 22-

  Klein, Arnold W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; BETACAINE LA; COLLAGEN IMPLANT; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE;

BIOCOMPATIBILITY; ESTHETIC SURGERY; HUMAN; IMPLANTATION; INJECTION; LIP RECONSTRUCTION; LONGEVITY; NOTE; PLASTIC SURGERY; SKIN TEST; SURGICAL TECHNIQUE; TOPICAL ANESTHESIA; VASCULAR DISEASE;

EID: 0141781027     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (6)

1. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588-595.
2. Micheels P. Human anti-hyaluronic acid antibodies: is it possible? Dermatol Surg. 2001;27:185-191.
3. Lowe NJ. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001;45:930-933.
4. Lowe NJ. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol. 2003;148:379.
5. Schanz S, Schippert W, Ulmer A, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol. 2002;146:928-929.
6. Friedman PM, Mafong EA, Kauvar AN, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg, 2002;28:491-494.